Stryker To Pay $15M To End False Marketing Case

Law360, New York (January 18, 2012, 4:14 PM EST) -- Stryker Biotech LLC reached a plea agreement Wednesday in Massachusetts federal court under which it will pay $15 million to end a criminal case over illegal marketing of a bone surgery device.

The company submitted a change of plea agreement altering its not-guilty plea to guilty after the government filed a superseding indictment in the case changing its charges against the company. Stryker now pleads guilty to one misdemeanor count of misbranding a medical device.

“Stryker Biotech expressly and unequivocally admits that it committed the misdemeanor...
To view the full article, register now.




Case Information

Case Title

USA v. Stryker Biotech, LLC et al

Case Number




Nature of Suit

Date Filed

October 28, 2009

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.